Horizon Pharma plc to Participate in Investor Conference in December
/EIN News/ -- DUBLIN, Ireland, Dec. 08, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will participate in the following conference in December:
The BMO Prescriptions for Success Healthcare Conference
- Date: December 14, 2016
- Presentation Time: 1:00 p.m. EST
- The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com, a replay of the webcast will also be available.
- Location: New York, NY
About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. Horizon Pharma markets 11 medicines through its orphan, rheumatology and primary care business units. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.
Contacts: Investors: Tina Ventura Senior Vice President, Investor Relations investor-relations@horizonpharma.com U.S. Media: Geoff Curtis Senior Vice President, Corporate Communications gcurtis@horizonpharma.com Ireland Media: Ray Gordon Gordon MRM ray@gordonmrm.ie
